2021 / 2022
|
06/03/22
| Shiruyeh Schokrpur, Postdoc Trainee
| Gutkind Lab
| Harnessing mRNA Delivery and the
XCL1-XCR1 Dendritic Cell Axis to
Enhance Cancer Response to Immunotherapy |
05/06/22
| Mark Kelly, Postdoc Trainee
| Ideker Lab
| Mapping Cancer Signaling Pathways
through In Situ Dominant Mutations |
04/01/22
| Dominic Schenone, Predoc Trainee
| Heinz Lab
| HOXB13 Estrogen Receptor (ER)
Re-programming in ER-Positive Breast Cancer |
03/04/22
| Alex Tankka, Predoc Trainee
| Yeo Lab
| Identifying RNA-Binding Protein Vulnerabilities
in Breast Cancers with
Unique Mutational Backgrounds |
02/04/22
| Stephanie Fraley, Ph.D.
| Associate Professor,
Department of Bioengineering
| Identifying Regulators of
Breast Cancer Heterogeneity through
Phenotypic Sorting and Single Cell Sequencing |
01/07/22
| Ryan Setten, Postdoc Trainee
| Yeo Lab
| Targetting the MLL-AF9 Oncogene
of AML with Antibody-Conjugated
Antisense-Oligonucleotide |
12/03/21
| Vineet Bafna, Ph.D.
| Professor, Department of
Computer Science & Engineering | Computational Methods for Analyzing
Extrachromosomal DNA in Cancer |
11/05/21
| Robert Signer, Ph.D.
| Assistant Professor, Department of
Medicine, Division of
Rengerative Medicine | Targetting the Proteostasis Network
in Normal and Malignant Stem Cells |
10/01/21
| Juan Hernandez, Predoc Trainee
| Huang Lab | Methyltransferase PRMT5 Promotes
Expression of Colon Tumor
Stem Cell Marker DCLK1 |
09/03/21
| Pradipta Ghosh,Ph.D.
| Professor, Cellular and Molecular
Medicine; Director, Institute for
Network Medicine | Grant Writing Workshop |
2020 / 2021
|
06/04/21
| Victoria Wu, Predoc Trainee;
Alexandra Tankka, Predoc Trainee;
Dominic Schenone, Predoc Trainee;
Ryan Setten, Ph.D.,
Postdoc Trainee
| Gutkind Lab;
Yeo Lab;
Sven Lab;
Dowdy Lab
| GPCRome in Tumor-Targeting T cells;
MicroRNA-mRNA Pairs in MYC-Driven Cancer;
HOXB13 Effects on ER+ Breast Cancer;
Targeting AML Oncogene
|
05/07/21
| External Advisory Committee Meeting
| with Trainees (55 minutes)
| with Executive Committee (35 minutes)
|
04/02/21
| Meghana Padagala, Predoc Trainee;
August Williams, Predoc Trainee;
Dan Cunningham-Bryant, Ph.D.,
Postdoc Trainee
| Carter Lab;
Hangauer Lab;
Ren Lab
|
Germine Variant Effects on Immunotherapy;
Apoptotic Nuclease Drives Drug Resistance;
Spatial Epigenomics in Tissues
|
03/05/21
| Ryan Setten, Postdoc Trainee
| Dowdy Lab
|
Targeted Ablation of AML Oncogene with
Antibody-Conjugated RNAi
|
03/05/21
| Dominic Schenone,
Predoc Trainee
| Heinz Lab
| HOXB13 Estrogen Receptor Reprogramming in
HR+ Breast Cancer
|
02/05/21
| Alexandra Tankka,
Predoc Trainee
| Yeo Lab
|
Identification of microRNA-mRNA gene silencing
interactions required for MYC-driven cancer growth
|
02/05/21
| Victoria Wu, Predoc Trainee
| Gutkind Lab
|
Targeting the Prostaglandin Receptor Gas
Signaling Axis as a Novel Immune Checkpoint
of CytotoxicT-Cells in Cancer
|
01/08/21
| Dan Cunningham-Bryant, Ph.D.
| Ren Lab
|
Deciphering Context-Specific Enhancer Function
Using Highly Multiplexed Imaging
|
01/08/21
| Esther Park, Ph.D.
| Rich Lab
|
Targeting Cancer-Specific Innatye Immunity with
Zika Virus
|
12/04/20
| August Williams, Predoc Trainee
| Hangauer Lab
| Revealing the Origin of Acquired Drug Resistance
Mutations in Cancer
|
12/04/20
| Meghana Pagadala, Predoc
Trainee
| Carter Lab
|
Germline Variants that Modify Tumor-Immune
Interactions
|
11/06/20
| Chris Putnam, Ph.D.
| Assistant Professor, Department of
Medicine
|
CRISPR Pickels & Bagel
|
10/02/20
| Jason Sicklick, MD
| Professor and Executive Vice Chair
of Research, Department of Surgery
|
Gastrointestinal Stromal Tumor: Slicing the
Genomic Pie and Cutting Through the Tumor
Microenvironment
|
09/04/20
| Ed Stites, MD, Ph.D.
| Assitant Professor, Hearst Foundation
Developmental Chair, Salk Institute for
Biological Sciences
|
Understanding Your Data and How it is Analyzed
|
2019 / 2020
|
06/05/20
| Dan Cunningham-Bryant, Ph.D.
| Ren Lab
| Engineering Chromatin Loops to Interrogate Role
of Chromatin Structure in Oncogenesis
|
05/01/20
| Dan Lorenz, Ph.D.
| Yeo Lab
| Using direct RNA sequencing to uncover RNA
modifications in cancer
|
04/03/20
| Victoria Wu, Predoc Trainee
| Gutkind Lab
|
Targeting cancer-specific innate immunity with
Zika virus
|
02/07/20
| August Williams, Predoc Trainee
| Hangauer Lab
|
Revealing the Origin of Acquired Drug Resistance
Mutations in Cancer
|
01/10/20
| Meghana Pagadala,
Predoc Trainee
| Carter Lab
|
Germline Variants That Modify Tumor-Immune
Interactions
|
12/06/19
| Erica Silva, Predoc Trainee
| Ideker Lab
|
A Dynamic Perspective of DNA Damage Response
|
11/01/19
| Ludmil Alexandrov, Ph.D.
| Assistance Professor, Department of
Cellular and Molecular Medicine
|
The Repertoire of Mutational Signatures in Human
Cancer
|
10/04/19
| Debashis Sahoo, Ph.D.
| Assistant Professor, Department of
Pediatrics
|
Developing Computational Models of Biological
Systems Using Boolean Implication Network
|
09/06/19
| Bing Ren, Ph.D.
| Professor, Department of Cellular and
Molecular Medicine
| Single-Cell Analysis of Genome Regulation
|
2018 / 2019
|
06/07/19
| Dan Lorenz, Ph.D.
| Yeo Lab
| Using direct RNA sequencing to uncover RNA
modifications in cancer
|
05/03/19
| Jason Ear, Ph.D.
| Ghosh Lab
| Subcellular localization of Daple regulates distinct
function during CRC progression
|
04/05/19
| Soo Park, MD
| Bajar Lab
| DNA methylation patterns in response to
hypomethylating agents in MDS
|
03/01/19
| Ayush Kishore, Ph.D.
| Gutkind Lab
| Targeting G protein-coupled receptors in
glioblastoma stem cells
|
02/01/19
| Carlos Medina, Predoc Trainee
| Dowdy Lab
|
Role of MLL-AF9 fusion oncogene in
establishment, maintenance, and recurrence of
Acute Myeloid Leukemia
|
01/04/19
| Myan Do, Predoc Trainee
| Willert Lab
|
WNT/FZD7 signaling in stem cells and cancer
|
12/07/18
| Erica Silva, Predoc Trainee
| Ideker Lab
| A dynamic perspective of DNA damage response
|
11/02/18
| Elaine Guo, Predoc Trainee
| Kolodner Lab
|
Effects of FEN1 loss on cancer cells with BRCA1 or
BRCA2 defects
|
10/05/18
| Gene Yeo, Ph.D.
| Professor, Department of
Cellular and Molecular
Medicine
|
RNA binding proteins: Engineers of human health
|
09/07/18
| Chris Putnam, Ph.D.
| Assistant Professor of Medicine
|
Strategies for understanding results from large
genetic screens
|
|
2017 / 2018 |
|
06/01/18 | Tariq Rana, Ph.D. | Professor of Pediatrics |
TBD |
|
05/04/18 | Olivier Harismendy, Ph.D.
| Asst. Professor of Medicine |
Evolution and Characterization of Chemo-Resistance at Single-Cell Resolution
|
|
04/06/18 | S. Park, MD | Bejar Lab |
Genomic Correlates of IL-2 Response in Advanced Melanoma and Renal Cell Carcinoma
|
|
03/02/18 | Ayush Kishore, Ph.D. | Gutkind Lab |
GNAQ-FAK Signaling in Ocular Melanoma |
|
02/02/18 | Nathan Jameson | Furnari Lab |
Epigenetic regulation of EGFR in Glioblastoma |
|
01/05/18 | Peter Ly, Ph.D. | NIH Pathway to Independence Awardee |
Rebuilding After Catastrophe: How Cell Division Errors Shape the Cancer Genome |
|
12/01/17 | Elaine Guo, BS | Kolodner Lab |
Synthetic Lethal Targeting of BRCA-Deficient Cancer |
|
11/03/17 | Jason Ear, Ph.D. | Ghosh Lab |
Dissecting the Role of DAPLE in Colorectal Cancer |
|
10/06/17 | Carlos Medina, BS | Dowdy Lab |
Genomics of Recurrent Acute Myeloid Leukemia |
09/01/17
| Myan Do, BA | Willert Lab |
Wnt Receptor FZD7 in Cancers and ES Cells |
|
2016 / 2017 |
|
06/02/17 | Jill Mesirov, Ph.D. | Medicine |
Computational Cancer Genomics |
|
05/05/17 | Nathan Jameson, Predoc Trainee | Furnari Lab |
Understanding EGFRVIII Genomic Breakpoints through CRISPR Modeling |
|
04/07/17 | Wendy Huang, Ph.D. | Cellular and Molecular Medicine |
RNA Helicases and Non-Coding RNA in Immune Regulation |
|
03/03/17 | Mohit Jain, MD, Ph.D. | Medicine and Pharmacology |
Cancer Metabolomics |
|
02/03/17 | Sven Heinz, Ph.D. | Cellular and Molecular Medicine |
Medical Epigenomics in Chronic Lymphocytic Leukemia |
|
01/06/17 | Matteo D'Antonio, Ph.D. | Frazer Lab |
Kataegis Expression Signature in Breast Cancer is Associated with Late Onset, Better Prognosis and Higher HER2 Levels |
|
12/02/16 | Jin Zhang, Ph.D. | Pharmacology |
Spatiotemporal Regulation of Signaling |
|
11/04/16 | Hannah Carter, Ph.D. | Medicine and Bioengineering |
Network Perturbing Cancer Mutations |
|
10/07/16 | Guowei Wu | Fu Lab |
SRPK1 Inhibition in Cancer Signaling |
|
09/09/16 | Debashis Sahoo, Ph.D. | Pediatrics and Computer Science |
A New Framework to Understand Cancer Cells
|
|
2015 / 2016 |
|
05/06/16 | Christie Eissler, Ph.D. | Zhou Lab |
The Role of Sumoylation in Chromosome Translocation |
|
04/01/16 | Guowei Wu | Fu Lab |
SRPK1: A Tumor Suppressor, Oncogene or Both? |
|
03/04/16 | Elaine Guo | Kolodner Lab |
Synthetic Lethality Relationships Involving Genome Instability |
|
02/05/16 | Nicholas Kalogriopoulos | Ghosh Lab |
Cross-Talk Between RTKs and Trimeric G Proteins |
|
01/08/16 | Nathan Jameson | Furnari Lab |
Chromatin Dynamics and Dysregulation Caused by EGFRvIII Deletion in Glioblastoma |
|
12/04/15 | Xiang-Dong Fu, Ph.D. | Fu Lab |
SRPK1: A Potential Key Cancer Target |
|
11/06/15 | Peter Ly, Ph.D. | Cleveland Lab |
Fragmentation and Reassembly of a Specific Human Chromosome in Micronuclei |
|
10/02/15 | Kelly Frazer, Ph.D. | Pediatrics |
Identification of Driver Mutations in Distal Regulatory Elements in Breast Cancer |
|
09/04/15 | Clark Chen, MD/Ph.D. | Neurosurgery |
Epigenetic Regulation of Glioblastoma Tumor Initiation |
|
2014 / 2015 |
|
07/10/15 | Jun Bao Fan, Ph.D. | Zhang Lab |
ISG15/Protein in Cancer Development: Friend or Foe? |
|
06/05/15 | Sebastian Gomez-Cavazos, Ph.D. | Oegema Lab |
Exploring the roles of Plk1 and the Chromosome Passenger Complex during Cytokinesis |
|
05/01/15 | Aaron Springer | Dowdy Lab |
Treating Cancer with BioReversible Prodrug RNAi Therapeutics |
|
04/03/15 | Cara Bickers | Traver Lab |
Lineage Tracing of Hematopoietic Stem and Progenitors in Zebrafish |
|
03/06/15 | Nicholas Kalogriopoulos | Ghosh Lab |
Role of G Proteins in Tumor Glucophagy: Lessons Learned From Diabetes |
|
02/13/15 | Christie Eissler, Ph.D. | Zhou Lab |
Investigating the Role of Protein SUMOylation in Cell Cycle Dynamics and Genome Stability |
|
01/09/15 | Gen-Sheng Feng, Ph.D. | Feng Lab |
Dissecting the Contradictory Roles of Signaling Molecules in Liver Cancer |
|
12/05/14 | Maricel Gozo, Ph.D. | Cheresh Lab |
Stress-Induced Reprogramming of Epithelial Cancers |
|
11/07/14 | Pradipta Ghosh, MD/Ph.D. | Ghosh Lab |
Molecular Engineering to Explore, Access, and Modulate a Cancer Cell's Signaling Code |
|
10/03/14 | Paul Mischel, Ph.D. | Mischel Lab |
Targeting EGFR-P13-mTOR Signaling: A Central Role of mTORC2 in Cancer Metabolic Reprogramming |
|
09/05/14 | Karen Oegema, Ph.D. | Oegema Lab |
Dynamic Cytoskeletal Rearrangement Underlying Cell Division in Cancer |
|
2013 / 2014 |
|
07/11/14 | Steve Dowdy, Ph.D. | Dowdy Lab |
Death of a Dogma, Cyclin D Activates Rb by Mono-Phosphorylation |
|
06/06/14 | Aaron Springer | Dowdy Lab |
Treating Cancer with BioReversible siRNN Produg RNAi Therapeutics |
|
05/02/14 | Julia Nussbacher | Yeo Lab |
Roles of RNA Binding Proteins in RNA Metabolism and Protein Translation |
|
04/04/14 | Amelia Richardson | Desai Lab |
Functional Analysis of Cohesin Mutants in Human Cancer |
|
03/07/14 | Trey Ideker, Ph.D. | Ideker Lab |
Mapping the Genetic Networks of Cancer |
|
02/07/14 | Kun-Liang Guan, Ph.D. | Guan Lab |
The Hippo-YAP Pathway in Organ Size Control and Tumorigenesis |
|
01/10/13 | Cara Bickers | Traver Lab |
Building Tools for a Zebrafish Leukemia Model |
|
12/06/13 | Frank Furnani, Ph.D. | Furnani Lab |
EGF Receptor in Glioma Biology: Therapeutic Target and a Multifaceted Driver of Pathogenicity |
|
11/01/13 | Peter Ly, Ph.D. | Cleveland Lab |
Chromosomal Fragmentation Chromothripsis in Cancer |
|
10/04/13 | Maricel Gozo, Ph.D. | Cheresh Lab |
Determining Novel Strategies to Overcome EGFR Resistance |
|
09/06/13 | David Traver, Ph.D. | Traver Lab |
Normal and Neoplastic Hematopoiesis |
|
2013 / 2012 |
|
07/05/13 | Richard Kolodner, Ph.D. | Kolodner Lab |
DNA Damage Repair Mechanisms Drive Cancer |
|
06/07/13 | Stephanie Weng | Zhang Lab |
Exploring Mechanisms to Reduce Leukemogenic Potential of AML-1-ETO |
|
05/03/13 | Alex Hamil | Dowdy Lab |
siRNN Induced RNAi Responses to Treat Cancer |
|
04/05/13 | Gene Yeo, Ph.D. | Yeo Lab |
Studies of RNA Binding Proteins Associated with Neurological Disease |
|
02/01/13 | Brian Thacker
| Esko Lab |
The Role of Heparan Sulfate 3-O Sulfation in Tumor Angiogenesis |
|
01/04/13 | Nicholas Vinckier | Sander Lab |
The Roles of SOX9, HES1, and NGN3 in Progression of Pancreatic Ductal Adnocarcinoma (PDAC) |
|
12/07/12 | Julia Nussbacher | Yeo Lab |
RNA Binding Protein Regulation of RNA Metabolism |
|
11/02/12 | Pradipta Ghosh, MD/Ph.D. | Ghosh Lab |
Transactivation of G-Protein by Tyrosine Kinases |
|
10/05/12 | Kirsten Ludwig, Ph.D. | Wang Lab |
Stem Cell Growth Factor Control of Colon Cancer Invasiveness |
|
09/07/12 | Amelia Richardson | Desai Lab |
Cohesin Complexes Mutations in Cancer |
|
2011 / 2012 |
|
06/01/12 | Nicholas Vinckier | Sander Lab |
Notch Signaling in Progression of Pancreatic Ductal Adenocarcinoma (PDAC) |
|
05/04/12 | Alex Hamil | Dowdy Lab |
Induction of Synthetic Lethal RNAi Response to Treat Cancer |
|
04/06/12 | Anthony Beas | Farquhar Lab |
Gas Regulation of EEA1 Shuts Down Proliferation Signaling Through GIV (Girdin) |
|
03/02/12 | Stephanie Weng | Zhang Lab |
Haploinsufficiency in t(8;21) AML Patients |
|
02/03/12 | Brian Thacker | Esko Lab |
Heparan Sulfate 3-O Sulfotransferases in Cancer |
|
01/06/12 | Jean Wang, Ph.D. | Wang Lab |
Resistance of Leukemic Stem Cells to Oncogene Targeted Therapies |
|
12/02/11 | Spencer Wei | Yang Lab |
Epithelial-Mesenchymal Transition (EMT) Programming During Breast Cancer Metastasis |
|
11/01/11 | Brian Meade | Dowdy Lab |
Development of Novel RNAi Therapeutics with New Synthetic Chemistry |
|
10/07/11 | Kirsten Ludwig, Ph.D. | Wang Lab |
p190RhoGap and Anillin Modulation of Rho-GTP During Cleavage Furrow Formation |
|
09/09/11 | Steve Dowdy, Ph.D. | Dowdy Lab |
Regulation of G1 Cell Cycle Progression in Cancer |